Ellomay Capital (NYSE: ELLO) awards 1,000 stock options to board director

Rhea-AI Filing Summary

Ellomay Capital Ltd. director Daniel Vaknin received an annual grant of 1,000 stock options on August 1, 2026 under the Issuer's 1998 Share Option Plan for Non-Employee Directors. The options have a $19.60 exercise price, become exercisable August 1, 2027, are subject to his continued board service on that date, and expire August 1, 2036, leaving him with 1,000 options.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Vaknin Daniel

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1, F2	1,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 1,000 shares (Direct)

Footnotes (2)

1. F1. On August 1, 2026, the Reporting Person received an annual grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors.
2. F2. Subject to the Reporting Person serving as a member of the Issuer's Board of Directors on such date.

Key Figures

Stock options granted: 1,000.0000 options Exercise price: $19.6000 per share Underlying ordinary shares: 1,000.0000 shares +3 more

6 metrics

Stock options granted 1,000.0000 options Annual grant to director Daniel Vaknin on August 1, 2026

Exercise price $19.6000 per share Exercise price of the granted stock options

Underlying ordinary shares 1,000.0000 shares Ordinary shares underlying the granted stock options

Options exercisable date 2027-08-01 Date on which options become exercisable, subject to continued board service

Options expiration date 2036-08-01 Expiration date of the director stock options

Derivative holdings after grant 1,000.0000 options Total stock options reported as held following this transaction

Key Terms

Stock Option (right to buy), exercise price, expiration date, 1998 Share Option Plan for Non-Employee Directors

4 terms

Stock Option (right to buy) financial

"security title listed as Stock Option (right to buy)"

exercise price financial

"conversion or exercise price reported as 19.6000"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"options carry an expiration date of 2036-08-01"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

1998 Share Option Plan for Non-Employee Directors financial

"annual grant of options under the Issuer's 1998 Share Option Plan for Non-Employee Directors"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 04:10 PM Accepted by SEC EDGAR 08/04/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What transaction did Ellomay Capital (ELLO) director Daniel Vaknin report?

Daniel Vaknin reported receiving an annual grant of 1,000 stock options on August 1, 2026. The options are granted under Ellomay Capital’s 1998 Share Option Plan for Non-Employee Directors and give him the right to buy 1,000 ordinary shares if exercised.

What is the exercise price of Daniel Vaknin’s Ellomay Capital (ELLO) stock options?

The granted options carry an exercise price of $19.60 per share. This is the price at which Vaknin may purchase Ellomay Capital ordinary shares upon exercise of the options, subject to the stated exercisability and service conditions.

When do Daniel Vaknin’s newly granted Ellomay Capital (ELLO) options become exercisable?

The options become exercisable on August 1, 2027. Exercisability is conditioned on Vaknin serving as a member of Ellomay Capital’s Board of Directors on that date, as specified in the option grant footnote.

When do the Ellomay Capital (ELLO) director stock options granted to Daniel Vaknin expire?

The stock options are scheduled to expire on August 1, 2036. After this expiration date, Vaknin will no longer be able to exercise these particular options to purchase Ellomay Capital ordinary shares.

How many Ellomay Capital (ELLO) stock options does Daniel Vaknin hold after this grant?

Following the reported grant, Vaknin holds 1,000 stock options in total as reflected in this filing. These options correspond to 1,000 underlying Ellomay Capital ordinary shares if fully exercised.

What condition affects Daniel Vaknin’s ability to exercise his Ellomay Capital (ELLO) options?

Exercising the options is subject to Vaknin serving as a member of Ellomay Capital’s Board on August 1, 2027. If he is not serving on the board then, the exercisability condition described in the footnote would not be met.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vaknin Daniel

(Last) (First) (Middle)

18 ROTHSCHILD BLVD.

(Street)

TEL AVIV 6688121

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ellomay Capital Ltd. [ ELLO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol
[ELLO]

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$19.6	08/01/2026(1)		A		1,000		08/01/2027(2)	08/01/2036	Ordinary Shares	1,000	$0	1,000	D

Explanation of Responses:

1. On August 1, 2026, the Reporting Person received an annual grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors.

2. Subject to the Reporting Person serving as a member of the Issuer's Board of Directors on such date.

	/s/ Daniel Vaknin	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)